{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:53:55Z","timestamp":1787003635596,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"US","award":["P30CA2401399"],"award-info":[{"award-number":["P30CA2401399"]}]},{"name":"National Cancer Institute","award":["U54CA221208"],"award-info":[{"award-number":["U54CA221208"]}]},{"name":"the National University of La Plata","award":["M250 I+D grant"],"award-info":[{"award-number":["M250 I+D grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08564-4","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:22:43Z","timestamp":1760088163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Integrative functional genomics analysis of Kaposi sarcoma cohorts"],"prefix":"10.1038","volume":"15","author":[{"given":"Ezequiel","family":"Lacunza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Naipauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda E.","family":"Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Gun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary J.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sion","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda I.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Coso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel","family":"Cesarman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn C.","family":"Abba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"issue":"1","key":"8564_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","volume":"5","author":"E Cesarman","year":"2019","unstructured":"Cesarman, E. et al. Kaposi sarcoma. Nat. Rev. Dis. Primers 5(1), 9 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"9","key":"8564_CR2","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1172\/JCI84418","volume":"126","author":"DP Dittmer","year":"2016","unstructured":"Dittmer, D. P. & Damania, B. Kaposi sarcoma\u2013associated herpesvirus: Immunobiology, oncogenesis, and therapy. J. Clin. Investig. 126(9), 3165\u20133175 (2016).","journal-title":"J. Clin. Investig."},{"issue":"10","key":"8564_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrc2888","volume":"10","author":"EA Mesri","year":"2010","unstructured":"Mesri, E. A., Cesarman, E. & Boshoff, C. Kaposi\u2019s sarcoma and its associated herpesvirus. Nat. Rev. Cancer 10(10), 707\u2013719 (2010).","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"8564_CR4","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.molmed.2022.12.003","volume":"29","author":"J Naipauer","year":"2023","unstructured":"Naipauer, J. & Mesri, E. A. The Kaposi\u2019s sarcoma progenitor enigma: KSHV-induced MEndT-EndMT axis. Trends Mol. Med. 29(3), 188\u2013200. https:\/\/doi.org\/10.1016\/j.molmed.2022.12.003 (2023).","journal-title":"Trends Mol. Med."},{"issue":"5","key":"8564_CR5","doi-asserted-by":"publisher","first-page":"e29684","DOI":"10.1002\/jmv.29684","volume":"96","author":"E Lacunza","year":"2024","unstructured":"Lacunza, E. et al. Unveiling the role of KSHV-infected human mesenchymal stem cells in Kaposi\u2019s sarcoma initiation. J. Med. Virol. 96(5), e29684. https:\/\/doi.org\/10.1002\/jmv.29684 (2024).","journal-title":"J. Med. Virol."},{"issue":"23","key":"8564_CR6","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1056\/NEJM198506063122314","volume":"312","author":"HW Haverkos","year":"1985","unstructured":"Haverkos, H. W. & Drotman, D. P. Prevalence of Kaposi\u2019s sarcoma among patients with AIDS. N. Engl. J. Med. 312(23), 1518 (1985).","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"8564_CR7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.2105\/AJPH.2018.304560","volume":"108","author":"LM Hutchison","year":"2018","unstructured":"Hutchison, L. M., Boscoe, F. P. & Feingold, B. J. Cancers disproportionately affecting the New York state transgender population, 1979\u20132016. Am. J. Public Healths 108(9), 1260\u20131262 (2018).","journal-title":"Am. J. Public Healths"},{"issue":"8","key":"8564_CR8","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/cid\/cix480","volume":"65","author":"AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord","year":"2017","unstructured":"AIDS-defining Cancer Project Working Group for IeDEA and COHERE in EuroCoord. Comparison of Kaposi sarcoma risk in human immunodeficiency virus-positive adults across 5 continents: A multiregional multicohort study. Clin. Infect. Dis. 65(8), 1316\u20131326. https:\/\/doi.org\/10.1093\/cid\/cix480 (2017).","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"8564_CR9","doi-asserted-by":"publisher","first-page":"e1006844","DOI":"10.1371\/journal.ppat.1006844","volume":"14","author":"FY Tso","year":"2018","unstructured":"Tso, F. Y. et al. RNA-Seq of Kaposi\u2019s sarcoma reveals alterations in glucose and lipid metabolism. PLoS Pathog. 14(1), e1006844 (2018).","journal-title":"PLoS Pathog."},{"issue":"12","key":"8564_CR10","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1002\/ijc.34689","volume":"153","author":"R Moorad","year":"2023","unstructured":"Moorad, R. et al. A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory. Int. J. Cancer 153(12), 2082\u20132092. https:\/\/doi.org\/10.1002\/ijc.34689 (2023).","journal-title":"Int. J. Cancer"},{"issue":"1","key":"8564_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1186\/s12967-023-04517-5","volume":"21","author":"R Ramaswami","year":"2023","unstructured":"Ramaswami, R. et al. Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis. J. Transl. Med. 21(1), 653 (2023).","journal-title":"J. Transl. Med."},{"issue":"17","key":"8564_CR12","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.18632\/oncotarget.27569","volume":"11","author":"SJ Lidenge","year":"2020","unstructured":"Lidenge, S. J. et al. Lack of CD8+ T-cell co-localization with Kaposi\u2019s sarcoma-associated herpesvirus infected cells in Kaposi\u2019s sarcoma tumors. Oncotarget 11(17), 1556\u20131572 (2020).","journal-title":"Oncotarget"},{"issue":"7","key":"8564_CR13","doi-asserted-by":"publisher","first-page":"e1008681","DOI":"10.1371\/journal.ppat.1008681","volume":"16","author":"SJ Lidenge","year":"2020","unstructured":"Lidenge, S. J. et al. Comparative transcriptome analysis of endemic and epidemic Kaposi\u2019s sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis. PLoS Pathog. 16(7), e1008681 (2020).","journal-title":"PLoS Pathog."},{"issue":"12","key":"8564_CR14","doi-asserted-by":"publisher","first-page":"e1007441","DOI":"10.1371\/journal.ppat.1007441","volume":"14","author":"TM Rose","year":"2018","unstructured":"Rose, T. M. et al. Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoter. PLoS Pathog. 14(12), e1007441 (2018).","journal-title":"PLoS Pathog."},{"issue":"2","key":"8564_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.canlet.2011.02.006","volume":"305","author":"TS Uldrick","year":"2011","unstructured":"Uldrick, T. S. & Whitby, D. Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett. 305(2), 150\u2013162 (2011).","journal-title":"Cancer Lett."},{"issue":"5","key":"8564_CR16","doi-asserted-by":"publisher","first-page":"e28773","DOI":"10.1002\/jmv.28773.PMID:37212317;PMCID:PMC10266714","volume":"95","author":"B Damania","year":"2023","unstructured":"Damania, B. & Dittmer, D. P. Today\u2019s Kaposi sarcoma is not the same as it was 40 years ago, or is it?. J. Med. Virol. 95(5), e28773. https:\/\/doi.org\/10.1002\/jmv.28773.PMID:37212317;PMCID:PMC10266714 (2023).","journal-title":"J. Med. Virol."},{"issue":"24","key":"8564_CR17","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1093\/bioinformatics\/btw538","volume":"32","author":"S Manimaran","year":"2016","unstructured":"Manimaran, S. et al. BatchQC: Interactive software for evaluating sample and batch effects in genomic data. Bioinformatics 32(24), 3836\u20133838. https:\/\/doi.org\/10.1093\/bioinformatics\/btw538 (2016).","journal-title":"Bioinformatics"},{"issue":"3","key":"8564_CR18","doi-asserted-by":"publisher","first-page":"Iqaa078","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Parmigiani, G. & Johnson, W. E. ComBat-seq: Batch effect adjustment for RNA-seq count data. NAR Genom. Bioinform. 2(3), Iqaa078 (2020).","journal-title":"NAR Genom. Bioinform."},{"issue":"6","key":"8564_CR19","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","volume":"26","author":"G Monaco","year":"2019","unstructured":"Monaco, G. et al. RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep. 26(6), 1627-1640.e7 (2019).","journal-title":"Cell Rep."},{"key":"8564_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht, E. et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 17, 218 (2016).","journal-title":"Genome Biol."},{"key":"8564_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0546-8","author":"MJ Goldman","year":"2020","unstructured":"Goldman, M. J. et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-020-0546-8 (2020).","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"8564_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00262-017-2058-z","volume":"67","author":"F Petitprez","year":"2018","unstructured":"Petitprez, F. et al. Transcriptomic analysis of the tumor microenvironment to guide prognosis and immunotherapies. Cancer Immunol. Immunother. 67(6), 981\u2013988. https:\/\/doi.org\/10.1007\/s00262-017-2058-z (2018).","journal-title":"Cancer Immunol. Immunother."},{"issue":"10","key":"8564_CR23","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/cup.13716","volume":"47","author":"B Joest","year":"2020","unstructured":"Joest, B. et al. Stage-related PD-L1 expression in Kaposi sarcoma tumor microenvironment. J. Cutan. Pathol. 47(10), 888\u2013895. https:\/\/doi.org\/10.1111\/cup.13716 (2020).","journal-title":"J. Cutan. Pathol."},{"key":"8564_CR24","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-3485","author":"AQ Lee","year":"2024","unstructured":"Lee, A. Q., Hao, C., Pan, M., Ganjoo, K. N. & Bui, N. Q. Histologic and immunologic factors associated with response to immune checkpoint inhibitors in advanced sarcoma. Clin. Cancer Res. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-3485 (2024).","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 1","key":"8564_CR25","doi-asserted-by":"publisher","first-page":"P88","DOI":"10.1186\/2049-3002-2-S1-P88","volume":"2","author":"Y Zhu","year":"2014","unstructured":"Zhu, Y., da Silva, S. R. & Gao, S. J. Metabolic reprogramming by KSHV in cellular transformation. Cancer Metab. 2(Suppl 1), P88. https:\/\/doi.org\/10.1186\/2049-3002-2-S1-P88 (2014).","journal-title":"Cancer Metab."},{"key":"8564_CR26","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.1128\/JVI.01587-07","volume":"82","author":"G Rappocciolo","year":"2008","unstructured":"Rappocciolo, G. et al. Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN. J. Virol. 82, 4793\u20134806. https:\/\/doi.org\/10.1128\/JVI.01587-07 (2008).","journal-title":"J. Virol."},{"key":"8564_CR27","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1172\/JCI44417","volume":"121","author":"G Ballon","year":"2011","unstructured":"Ballon, G., Chen, K., Perez, R., Tam, W. & Cesarman, E. Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. J. Clin. Invest. 121, 1141\u20131153. https:\/\/doi.org\/10.1172\/JCI44417 (2011).","journal-title":"J. Clin. Invest."},{"issue":"8","key":"8564_CR28","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1128\/JVI.02377-15","volume":"90","author":"SM Nicol","year":"2016","unstructured":"Nicol, S. M. et al. Primary B lymphocytes infected with Kaposi\u2019s sarcoma-associated herpesvirus can be expanded in vitro and are recognized by LANA-specific CD4+ T cells. J. Virol. 90(8), 3849\u20133859. https:\/\/doi.org\/10.1128\/JVI.02377-15 (2016).","journal-title":"J. Virol."},{"key":"8564_CR29","doi-asserted-by":"publisher","first-page":"10696","DOI":"10.1073\/pnas.1004882107","volume":"107","author":"T Delgado","year":"2010","unstructured":"Delgado, T. et al. Induction of the Warburg effect by Kaposi\u2019s sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proc. Natl. Acad. Sci. USA 107, 10696\u201310701 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"8564_CR30","doi-asserted-by":"publisher","first-page":"e1007062","DOI":"10.1371\/journal.ppat.1007062.PMID:29746587;PMCID:PMC5963815","volume":"14","author":"RK Singh","year":"2018","unstructured":"Singh, R. K., Lang, F., Pei, Y., Jha, H. C. & Robertson, E. S. Metabolic reprogramming of Kaposi\u2019s sarcoma associated herpes virus infected B-cells in hypoxia. PLoS Pathog. 14(5), e1007062. https:\/\/doi.org\/10.1371\/journal.ppat.1007062.PMID:29746587;PMCID:PMC5963815 (2018).","journal-title":"PLoS Pathog."},{"issue":"13","key":"8564_CR31","doi-asserted-by":"publisher","first-page":"110144","DOI":"10.1016\/j.celrep.2021.110144.PMID:34965440;PMCID:PMC9121799","volume":"37","author":"O M\u00e9ndez-Sol\u00eds","year":"2021","unstructured":"M\u00e9ndez-Sol\u00eds, O. et al. Kaposi\u2019s sarcoma herpesvirus activates the hypoxia response to usurp HIF2\u03b1-dependent translation initiation for replication and oncogenesis. Cell Rep. 37(13), 110144. https:\/\/doi.org\/10.1016\/j.celrep.2021.110144.PMID:34965440;PMCID:PMC9121799 (2021).","journal-title":"Cell Rep."},{"issue":"9","key":"8564_CR32","doi-asserted-by":"publisher","first-page":"e1011169","DOI":"10.1371\/journal.ppat.1011169.PMID:37669313;PMCID:PMC10503724","volume":"19","author":"AT Olson","year":"2023","unstructured":"Olson, A. T. et al. Polypharmacology-based kinome screen identifies new regulators of KSHV reactivation. PLoS Pathog. 19(9), e1011169. https:\/\/doi.org\/10.1371\/journal.ppat.1011169.PMID:37669313;PMCID:PMC10503724 (2023).","journal-title":"PLoS Pathog."},{"issue":"2","key":"8564_CR33","doi-asserted-by":"publisher","first-page":"e0126823","DOI":"10.1128\/jvi.01268-23","volume":"98","author":"K Nakajima","year":"2024","unstructured":"Nakajima, K., Inagaki, T., Espera, J. M. & Izumiya, Y. Kaposi\u2019s sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation. J. Virol. 98(2), e0126823. https:\/\/doi.org\/10.1128\/jvi.01268-23 (2024).","journal-title":"J. Virol."},{"issue":"12","key":"8564_CR34","doi-asserted-by":"publisher","first-page":"4961","DOI":"10.3390\/v6124961.PMID:25514370;PMCID:PMC4276939","volume":"6","author":"T Uppal","year":"2014","unstructured":"Uppal, T., Banerjee, S., Sun, Z., Verma, S. C. & Robertson, E. S. KSHV LANA: The master regulator of KSHV latency. Viruses 6(12), 4961\u20134998. https:\/\/doi.org\/10.3390\/v6124961.PMID:25514370;PMCID:PMC4276939 (2014).","journal-title":"Viruses"},{"issue":"4","key":"8564_CR35","doi-asserted-by":"publisher","first-page":"e0124486","DOI":"10.1371\/journal.pone.0124486","volume":"10","author":"SM de Munnik","year":"2015","unstructured":"de Munnik, S. M. et al. The viral G protein-coupled receptor ORF74 hijacks \u03b2-arrestins for endocytic trafficking in response to human chemokines. PLoS ONE 10(4), e0124486. https:\/\/doi.org\/10.1371\/journal.pone.0124486 (2015).","journal-title":"PLoS ONE"},{"issue":"10","key":"8564_CR36","doi-asserted-by":"publisher","first-page":"e1009006","DOI":"10.1371\/journal.ppat.1009006","volume":"16","author":"MV Medina","year":"2020","unstructured":"Medina, M. V. et al. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi\u2019s sarcoma. PLoS Pathog. 16(10), e1009006. https:\/\/doi.org\/10.1371\/journal.ppat.1009006 (2020).","journal-title":"PLoS Pathog."},{"issue":"6","key":"8564_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.semcancer.2008.09.003","volume":"18","author":"C Liang","year":"2008","unstructured":"Liang, C., Lee, J. S. & Jung, J. U. Immune evasion in Kaposi\u2019s sarcoma-associated herpes virus associated oncogenesis. Semin. Cancer Biol. 18(6), 423\u2013436. https:\/\/doi.org\/10.1016\/j.semcancer.2008.09.003 (2008).","journal-title":"Semin. Cancer Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08564-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08564-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:22:46Z","timestamp":1760088166000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08564-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8564"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08564-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MJG is a consultant for the Fred Hutchinson Cancer Research Center. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35413"}}